Navigation Links
TaiGen Amends Global License Agreement with Warner Chilcott plc for Development and Commercialization of Nemonoxacin -- a New Generation Quinolone Antibiotic
Date:10/14/2010

European pharmaceuticals markets.

"We are very encouraged by the signing of the amended agreement with Warner Chilcott," said Dr. Ming-Chu, Hsu, Chairman and CEO of TaiGen. "The deal proved TaiGen's capabilities in conducting clinical and regulatory development with high quality and at standards set by the United States Food and Drug Administration (US FDA). It also validated TaiGen's business model of building R&D portfolio through both internal R&D and external collaboration and licensing."

With China being a fast growing pharmaceutical market, TaiGen, which set up its Beijing affiliate in 2005, has been developing nemonoxacin under the China SFDA (China State Food and Drug Administration) regulation. It is expected that nemonoxacin will enter Phase III development in China very soon.

About TaiGen Biotechnology

TaiGen Biotechnology (http://www.taigenbiotech.com ) is a leading development stage pharmaceutical company based in Taiwan with a wholly-owned subsidiary in Beijing, China. The company has a full capacity in discovery research and clinical development in mainland China/Taiwan/US. Its current pipeline includes therapeutics for infectious diseases, diabetic complications and cancer for the worldwide market.

Media Contacts: Dr. John Jin Vice President for Business Development Tel: +886-2-8177-7072 Email: johnjin@taigenbiotech.com
'/>"/>

SOURCE TaiGen Biotechnology Co., Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
3. TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints
4. KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)
5. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
6. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
7. Directors Forum: PEPFAR and the Global AIDS Response
8. Alfacell Corporation to Present at UBS Global Life Sciences Conference
9. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
10. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
11. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... May 1, 2015 Semler Scientific, Inc. (Nasdaq: ... that develops, manufactures and markets products that assist healthcare ... reported financial results for the first quarter ended March ... of 2015, Semler reported continued progress with year over ... revenue growth of 14%," said Doug Murphy-Chutorian , ...
(Date:5/1/2015)...  Shares of Aerie Pharmaceuticals, Inc. (NASDAQ: AERI ... the results of the Phase 3 Rocket 1 trail ... failing to meet its end points, compelling data from ... future studies. An analyst report on AERI ... review, analyst summary, valuation, and recommendation can be viewed ...
(Date:4/30/2015)... 30, 2015  Accuray Incorporated (Nasdaq: ARAY ... agreement with MIM Software Inc. to further develop ... and CyberKnife ® product portfolios. The new software ... This is Accuray,s second collaboration with MIM; the ... first iPad-based treatment plan review capability, PlanTouch™. ...
Breaking Medicine Technology:Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3
(Date:5/2/2015)... Kare Visits LLC. launched in Chicago in response to the ... offers relief for caregivers by visiting loved ones in nursing ... the Caregiver Action Network, eight in ten caregivers are employed. ... caring for an elderly or disabled loved one. For ... caregiver is now empowered to schedule an on demand visit ...
(Date:5/2/2015)... 2015 With the success that Veatch Dental ... to welcome Neida Miranda and Alex Shields to the team. ... over 41 years of combined experience working with dentists to ... dental field for 8 years. She was certified as ... Customer service, positive attitude and showing the importance of oral ...
(Date:5/1/2015)... Pioneer Millworks, the largest reclaimed wood company ... reclaimed wood products at the 27th annual International Contemporary ... NYC this May. Their newest offerings, Vat 35, Mushroom ... and color to North America's platform for global design. ... color in the design world and we're excited to ...
(Date:5/1/2015)... May 01, 2015 The Workgroup ... nonprofit authority on the use of health IT to ... key contributing resource to the United States Government Accountability ... electronically readable cards in Medicare. The report, “ Potential ... ” was released to the public on Apr. 24, ...
(Date:5/1/2015)... 2015 Hope For The Warriors® thanks ... For The Warriors® and military families. All American Ford ... For The Warriors®, a national nonprofit dedicated to restoring ... restoring hope for our service members and our military ... Ford collected and matched small autograph fee from fans ...
Breaking Medicine News(10 mins):Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:All American Ford Presents Donation to Nonprofit Hope For The Warriors 2
... Sept. 11 At a press conference held in Coral Gables ... of the organization,s alliance with Navarro Discount Pharmacies. Centro Mater is ... from six weeks to 12 years of age. The organization ... County - two in Hialeah, two in Little Havana, and one ...
... 11 During its 2009 Annual Conference in Washington, DC from September ... of the most pressing issues facing private care registries in the country ... include: , , , ... The program will cover PCA,s actions in the effort to hold ...
... GREENSBORO, N.C., Sept. 11 Merz Pharmaceuticals, LLC, a ... Food and Drug Administration (FDA) has accepted for review ... , , Belotero(R) Balance is a ... a cohesive polydensified matrix (CPM(TM)) technology. This application seeks ...
... , LOS ANGELES, Sept. 11 ... with singer/songwriter/actress/philanthropist Consuelo Vanderbilt Costin for Ovarian Cancer Awareness Month, ... against ovarian cancer. The campaign,s purpose is to educate ... of this deadly disease, support research and advocate for increased ...
... , LIBERTYVILLE, Ill., Sept. 11 They,re BAA-AACK! ... nationwide, the teeny, insidious bloodsuckers--which feast on sleeping humans--are making a ... being spotted in hotels from coast to coast. And not just ... a recent study of 700 mid-priced hotels, 25% were found to ...
... , , DALLAS, Sept. 11 ... (OTC Bulletin Board: ACCP) has entered into an ... North American distribution. One or more U.S. market seeding studies could ... In a comparison of cancer patients receiving standard oral mucositis ...
Cached Medicine News:Health News:Alliance Between Centro Mater and Navarro Discount Pharmacies 2Health News:Private Care Association to Tackle Major Issues Impacting Home Care Industry 2Health News:Merz Pharmaceuticals' Belotero(R) Balance PMA Filing Formally Accepted for Review by the FDA 2Health News:Ovarian Cancer Coalition Partners With Consuelo Vanderbilt Costin 2Health News:Rest Easy, the Safe, All-Natural Bed Bug Travel Spray 2Health News:Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States 2Health News:Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States 3Health News:Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States 4
... Featuring up to ... allows examination in the ... sections plus the option ... for corneal transillumination., ,Filters ...
... to 20 tilting tower ... the vertical, horizontal and ... option to offset the ... ,Filters include Cobalt blue; ...
... outstanding optical system of the Keeler SL-40H, ... fibre optic illumination system with diffuser added ... camera. The result is an excellent digital ... option of capturing stills or video clips ...
With a high lens and filter range this ophthalmoscope is ideal for the Primary Care Specialist...
Medicine Products: